Kardigan, Inc.

KARD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002123613

Price chart

Open-market purchases and sales by KARD insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Jun 24, 20269:26 PM ETJun 22, 2026HRTG GPE, LLC and 4 others10% OwnerPPurchaseCommon Stock+3.13M$16.00+$50M14.87M+26.6%SEC
Jun 24, 20264:18 PM ETJun 22, 2026CRANDELL KEITH and 6 othersDirector, 10% OwnerPPurchaseCommon Stock+1.25M$16.00+$20M15.04M+9.1%SEC
Jun 24, 2026Jun 22, 2026BERNS PAUL LDirector, 10% OwnerPPurchaseCommon Stock+1.25M$16.00+$20M15.04M+9.1%SEC

The largest institutional positions in KARD at the end of Q2 2026.

Institutions holding KARD in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
SCHF (GPE), LLC16,917,034$403.47M16.26%+16,917,034New
FMR LLC8,909,066$212.48M0.01%+8,909,066New
PERCEPTIVE ADVISORS LLC8,200,662$195.59M3.04%+8,200,662New
T. Rowe Price Investment Management, Inc.4,207,130$100.34M0.07%+4,207,130New
Capital Research Global Investors3,598,942$85.83M0.01%+3,598,942New